A detailed history of Itau Unibanco Holding S.A. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Itau Unibanco Holding S.A. holds 59 shares of MEDP stock, worth $19,914. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59
Holding current value
$19,914
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$372.0 - $424.34 $21,948 - $25,036
59 New
59 $24,000
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $5,232 - $7,191
-23 Reduced 20.0%
92 $28,000
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $233 - $281
-1 Reduced 0.86%
115 $27,000
Q2 2023

Aug 14, 2023

SELL
$187.26 - $240.17 $2,434 - $3,122
-13 Reduced 10.08%
116 $27,000
Q4 2022

Feb 09, 2023

SELL
$153.06 - $226.57 $4,591 - $6,797
-30 Reduced 18.87%
129 $27,000
Q2 2022

Aug 15, 2022

SELL
$130.2 - $168.03 $1,432 - $1,848
-11 Reduced 6.47%
159 $24,000
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $138 - $214
-1 Reduced 0.58%
170 $28,000
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $5,847 - $7,292
32 Added 23.02%
171 $37,000
Q3 2021

Nov 12, 2021

BUY
$170.18 - $198.21 $680 - $792
4 Added 2.96%
139 $26,000
Q2 2021

Aug 17, 2021

BUY
$158.62 - $194.3 $21,413 - $26,230
135 New
135 $24,000
Q2 2020

Aug 14, 2020

SELL
$68.08 - $95.68 $25,393 - $35,688
-373 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$61.71 - $101.95 $102,500 - $169,338
-1,661 Reduced 81.66%
373 $27,000
Q4 2019

Feb 14, 2020

BUY
$70.08 - $84.64 $142,542 - $172,157
2,034 New
2,034 $171,000
Q3 2019

Nov 14, 2019

SELL
$62.38 - $85.89 $307,096 - $422,836
-4,923 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$53.64 - $65.42 $264,069 - $322,062
4,923 New
4,923 $322,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.